[
  {
    "ts": "2026-01-29T09:00:00+00:00",
    "headline": "Questex Presents the 10th Annual Patients as Partners® in Clinical Trials Europe Conference",
    "summary": "Patients as Partners® Europe now part of Questex’s Fierce Life Sciences, brings pharma R&D and patient advocacy together in an international event this May 19-20 in LondonNEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Today, Questex announced the keynotes and topics for the 10th annual Patients as Partners® Europe conference happening May 19-20, 2026 at the Royal National Hotel, in London, UK. Sanofi, Johnson and Johnson, Roche and Parexel kick off the conference together with patient advocacy on h",
    "url": "https://finance.yahoo.com/news/questex-presents-10th-annual-patients-090000653.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "14d1c122-8156-3647-a7f8-11de76b00d37",
      "content": {
        "id": "14d1c122-8156-3647-a7f8-11de76b00d37",
        "contentType": "STORY",
        "title": "Questex Presents the 10th Annual Patients as Partners® in Clinical Trials Europe Conference",
        "description": "",
        "summary": "Patients as Partners® Europe now part of Questex’s Fierce Life Sciences, brings pharma R&D and patient advocacy together in an international event this May 19-20 in LondonNEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Today, Questex announced the keynotes and topics for the 10th annual Patients as Partners® Europe conference happening May 19-20, 2026 at the Royal National Hotel, in London, UK. Sanofi, Johnson and Johnson, Roche and Parexel kick off the conference together with patient advocacy on h",
        "pubDate": "2026-01-29T09:00:00Z",
        "displayTime": "2026-01-29T09:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/73decd2ea316fbf2bd0a868c43739ae5",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xtz.hN3IiV2tNXGz347aYg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/73decd2ea316fbf2bd0a868c43739ae5.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h.0pIdKJtyrPz12FZLcwKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/73decd2ea316fbf2bd0a868c43739ae5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/questex-presents-10th-annual-patients-090000653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/questex-presents-10th-annual-patients-090000653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T08:55:00+00:00",
    "headline": "The Zacks Analyst Blog  Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL",
    "summary": "Johnson & Johnson leads Zacks' latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major and micro-cap stocks.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-johnson-johnson-085500745.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5400b3c3-4bf2-3270-8750-45ed56ca0da9",
      "content": {
        "id": "5400b3c3-4bf2-3270-8750-45ed56ca0da9",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog  Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL",
        "description": "",
        "summary": "Johnson & Johnson leads Zacks' latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major and micro-cap stocks.",
        "pubDate": "2026-01-29T08:55:00Z",
        "displayTime": "2026-01-29T08:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/40014f41c9fe399fc1166da8b9186dd7",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7ryaulY1an_EnmKb80.UNw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/40014f41c9fe399fc1166da8b9186dd7.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nf0MccfYnvJkF1ZN9YtSxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/40014f41c9fe399fc1166da8b9186dd7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-johnson-johnson-085500745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-johnson-johnson-085500745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "ANET"
            },
            {
              "symbol": "AXIL"
            },
            {
              "symbol": "OFLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T12:12:02+00:00",
    "headline": "Johnson & Johnson Stock Rises After Morgan Stanley Upgrade",
    "summary": "Johnson & Johnson Stock Advances on New Overweight Rating",
    "url": "https://finance.yahoo.com/news/johnson-johnson-stock-rises-morgan-121202877.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "3e0c99bb-36f7-3473-aaa2-94c815d96998",
      "content": {
        "id": "3e0c99bb-36f7-3473-aaa2-94c815d96998",
        "contentType": "STORY",
        "title": "Johnson & Johnson Stock Rises After Morgan Stanley Upgrade",
        "description": "",
        "summary": "Johnson & Johnson Stock Advances on New Overweight Rating",
        "pubDate": "2026-01-29T12:12:02Z",
        "displayTime": "2026-01-29T12:12:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nQahFoVt6_qKzx8G6FoELg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yScmCasUkPZyvdIPPU4j.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-stock-rises-morgan-121202877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-stock-rises-morgan-121202877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T14:41:03+00:00",
    "headline": "PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls",
    "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential HSBC upgraded UPS (UPS) to Buy from Hold with a price target of $125, up from $100. Q4",
    "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-144103429.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "68206c75-dee7-3d89-92ad-21541d5d9d2f",
      "content": {
        "id": "68206c75-dee7-3d89-92ad-21541d5d9d2f",
        "contentType": "STORY",
        "title": "PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls",
        "description": "",
        "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential HSBC upgraded UPS (UPS) to Buy from Hold with a price target of $125, up from $100. Q4",
        "pubDate": "2026-01-29T14:41:03Z",
        "displayTime": "2026-01-29T14:41:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/b3fdc84be0326986f5b641950d19fc86",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/paypal-downgraded-ups-upgraded-wall-streets-top-analyst-calls-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d6403msI4LOwfcsjjwNaVg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b3fdc84be0326986f5b641950d19fc86.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JYj6hhTKf5.pzSaAfAT.cA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b3fdc84be0326986f5b641950d19fc86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-144103429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-144103429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCHP"
            },
            {
              "symbol": "MCHPP"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "COIN"
            },
            {
              "symbol": "V"
            },
            {
              "symbol": "ROP"
            },
            {
              "symbol": "UPS"
            },
            {
              "symbol": "CLS"
            },
            {
              "symbol": "TXN"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "NUE"
            },
            {
              "symbol": "TPG"
            },
            {
              "symbol": "BJ"
            },
            {
              "symbol": "AL"
            },
            {
              "symbol": "HTFL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T14:13:00+00:00",
    "headline": "Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results",
    "summary": "Healthcare ETFs draw attention as UNH climbs 4% on mixed Q4 results, a better 2026 cost outlook, and rising concerns over Medicaid pressure.",
    "url": "https://finance.yahoo.com/news/healthcare-etfs-focus-unitedhealth-rises-141300653.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f69c07f8-4fda-3d70-a66e-8e9ab81ccae2",
      "content": {
        "id": "f69c07f8-4fda-3d70-a66e-8e9ab81ccae2",
        "contentType": "STORY",
        "title": "Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results",
        "description": "",
        "summary": "Healthcare ETFs draw attention as UNH climbs 4% on mixed Q4 results, a better 2026 cost outlook, and rising concerns over Medicaid pressure.",
        "pubDate": "2026-01-29T14:13:00Z",
        "displayTime": "2026-01-29T14:13:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b452082c5bafce0b3d09c2a06d33f987",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eMZKTPGVX0X_.Y2x.teJ.g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b452082c5bafce0b3d09c2a06d33f987.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.xl8bUH1IJydtuVUgipu2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b452082c5bafce0b3d09c2a06d33f987.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-focus-unitedhealth-rises-141300653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etfs-focus-unitedhealth-rises-141300653.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UNH"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "IYH"
            },
            {
              "symbol": "ELV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "IHF"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T17:45:52+00:00",
    "headline": "Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 22, Scotiabank lifted its price target on Johnson & Johnson (NYSE:JNJ) to $265 from $230. The firm reiterated an Outperform rating after the company’s Q4 results. The bigger takeaway was how well J&J […]",
    "url": "https://finance.yahoo.com/news/scotiabank-raises-johnson-johnson-jnj-174552013.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d4696c7e-f2dc-3603-a0b6-8eb0da412f55",
      "content": {
        "id": "d4696c7e-f2dc-3603-a0b6-8eb0da412f55",
        "contentType": "STORY",
        "title": "Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 22, Scotiabank lifted its price target on Johnson & Johnson (NYSE:JNJ) to $265 from $230. The firm reiterated an Outperform rating after the company’s Q4 results. The bigger takeaway was how well J&J […]",
        "pubDate": "2026-01-29T17:45:52Z",
        "displayTime": "2026-01-29T17:45:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7570f952461ee2865dbfa209bc572816",
          "originalWidth": 8224,
          "originalHeight": 5490,
          "caption": "Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WwMKieqckFUjgziNVOy6Zw--~B/aD01NDkwO3c9ODIyNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/7570f952461ee2865dbfa209bc572816.cf.webp",
              "width": 8224,
              "height": 5490,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ahq.pgItEz57xP.r.9i82A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7570f952461ee2865dbfa209bc572816.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/scotiabank-raises-johnson-johnson-jnj-174552013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/scotiabank-raises-johnson-johnson-jnj-174552013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T17:42:00+00:00",
    "headline": "This Winning Fund Pro Likes J&J, Lowe’s, and Utility Stocks",
    "summary": "Susan Bao’s large-cap JPMorgan fund has outperformed the S&P 500 over many years. She’s bullish on stocks, focused on bargains.",
    "url": "https://www.barrons.com/articles/jnj-lowes-utilities-large-cap-stocks-e9ce45a7?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f48558c2-9e1c-37f2-a2d5-86b43581989a",
      "content": {
        "id": "f48558c2-9e1c-37f2-a2d5-86b43581989a",
        "contentType": "STORY",
        "title": "This Winning Fund Pro Likes J&J, Lowe’s, and Utility Stocks",
        "description": "",
        "summary": "Susan Bao’s large-cap JPMorgan fund has outperformed the S&P 500 over many years. She’s bullish on stocks, focused on bargains.",
        "pubDate": "2026-01-29T17:42:00Z",
        "displayTime": "2026-01-29T17:42:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f48558c2-9e1c-37f2-a2d5-86b43581989a/this-winning-fund-pro-likes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/9ba54a4addc75e15633ee660e7d3050e",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pD4.XIofX.vtXQhUq1tyOg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/9ba54a4addc75e15633ee660e7d3050e.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w9bIPe0eLuOUqUwMuoBbVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/9ba54a4addc75e15633ee660e7d3050e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/jnj-lowes-utilities-large-cap-stocks-e9ce45a7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LOW"
            },
            {
              "symbol": "NEE"
            },
            {
              "symbol": "NEE-PS"
            },
            {
              "symbol": "NEE-PT"
            },
            {
              "symbol": "JCPRX"
            },
            {
              "symbol": "JLCAX"
            },
            {
              "symbol": "JLPCX"
            },
            {
              "symbol": "JLPSX"
            },
            {
              "symbol": "JLPYX"
            },
            {
              "symbol": "JLPZX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T16:52:00+00:00",
    "headline": "HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance",
    "summary": "Halozyme Therapeutics' shares jump nearly 4% after preliminary 2025 results beat expectations and management lifts 2026 outlook.",
    "url": "https://finance.yahoo.com/news/halo-rises-nearly-4-strong-165200422.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "730c13b9-fb2c-395e-845a-e80d2ba06d74",
      "content": {
        "id": "730c13b9-fb2c-395e-845a-e80d2ba06d74",
        "contentType": "STORY",
        "title": "HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance",
        "description": "",
        "summary": "Halozyme Therapeutics' shares jump nearly 4% after preliminary 2025 results beat expectations and management lifts 2026 outlook.",
        "pubDate": "2026-01-29T16:52:00Z",
        "displayTime": "2026-01-29T16:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/halo-rises-nearly-4-strong-165200422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/halo-rises-nearly-4-strong-165200422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ARGX"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T20:09:35+00:00",
    "headline": "FDA Multiple Myeloma Approval Gives Fresh Catalyst To Johnson & Johnson",
    "summary": "The FDA approved a new DARZALEX FASPRO combination therapy for newly diagnosed multiple myeloma patients who are not eligible for stem cell transplant. The decision expands DARZALEX FASPRO’s indications and reinforces its role as a foundational treatment option in multiple myeloma care. This regulatory milestone is material for Johnson & Johnson, affecting treatment choices, its pharmaceutical pipeline, and potential revenue streams. For Johnson & Johnson (NYSE:JNJ), this approval adds...",
    "url": "https://finance.yahoo.com/news/fda-multiple-myeloma-approval-gives-200935151.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ca260852-98b1-3c81-a08c-9344414c9622",
      "content": {
        "id": "ca260852-98b1-3c81-a08c-9344414c9622",
        "contentType": "STORY",
        "title": "FDA Multiple Myeloma Approval Gives Fresh Catalyst To Johnson & Johnson",
        "description": "",
        "summary": "The FDA approved a new DARZALEX FASPRO combination therapy for newly diagnosed multiple myeloma patients who are not eligible for stem cell transplant. The decision expands DARZALEX FASPRO’s indications and reinforces its role as a foundational treatment option in multiple myeloma care. This regulatory milestone is material for Johnson & Johnson, affecting treatment choices, its pharmaceutical pipeline, and potential revenue streams. For Johnson & Johnson (NYSE:JNJ), this approval adds...",
        "pubDate": "2026-01-29T20:09:35Z",
        "displayTime": "2026-01-29T20:09:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-multiple-myeloma-approval-gives-200935151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-multiple-myeloma-approval-gives-200935151.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]